Search - tctmd.com

Displaying 181 - 200 of 599

Sort: Relevancy | Date

News Daily News

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

L.A. McKeown

December 07, 2015

News Daily News

Los Pacientes de Flujo y Gradiente Bajos son Más Propensos a Morir y Menos a someterse a la Sustitución de la Válvula Aórtica

L.A. McKeown

December 07, 2015

News Daily News

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Michael O'Riordan

December 06, 2015

News Opinion Fellow Talk

Ten Essential Adjunctive Skillsets for the Budding Structural Interventionist

Waleed Alharbi, MD

November 29, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Industry News

First Pennsylvania Patient Treated in Next Generation Aortic Heart Valve Study

November 10, 2015

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

Presentation

LVAD Therapy in End-Stage Heart Disease

Presenter: Matthias Loebe

October 30, 2015

News Industry News

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

October 26, 2015

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

Presentation TCT 2015

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Presenter: Michael J. Reardon, Torsten P. Vahl, Daniel O'Hair

October 13, 2015

News Industry News

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

October 13, 2015

News Conference News TCT 2015

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Todd Neale

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

Presentation TCT 2015

Severe Renal Disease and TAVR: Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Charles J. Davidson

October 12, 2015

Presentation TCT 2015

Severe Renal Disease and TAVR: Case Presentation

Presenter: Howard C. Herrmann, Patrick T. O'Gara, S. Chiu Wong

October 12, 2015

Advertisement

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

Los Pacientes de Flujo y Gradiente Bajos son Más Propensos a Morir y Menos a someterse a la Sustitución de la Válvula Aórtica

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Ten Essential Adjunctive Skillsets for the Budding Structural Interventionist

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

First Pennsylvania Patient Treated in Next Generation Aortic Heart Valve Study

Post-TAVR Myocardial Injury Linked to Mortality

LVAD Therapy in End-Stage Heart Disease

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

My Takeaways From TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Severe Renal Disease and TAVR: Thoughtful Commentary on the Case

Severe Renal Disease and TAVR: Case Presentation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content